ContractCollaboration Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020<DOCUMENT> <TYPE>EX-10.13.4 <SEQUENCE>3 <FILENAME>y17762exv10w13w4.txt <DESCRIPTION>EX-10.13.4: AMENDMENT NO. 4 TO COLLABORATION AGREEMENT <TEXT> <PAGE> EXHIBIT 10.13.4 FOURTH AMENDMENT TO COLLABORATION AGREEMENT This Fourth Amendment to Collaboration Agreement (this "Fourth Amendment") dated as of January 31, 2006 (the "Fourth Amendment Effective Date"), is by and between Regeneron Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of New York and having its principal office at 777 Old Saw Mill River Road, Tarrytown, New York 10591 ("Regeneron ") and sanofi-aventis U. S., LLC, (successor in interest to Aventis Pharmaceuticals Inc.), a limited liability company organized and existing under the laws of the State of Delaware and having a principal place of business at 200 Crossing Blvd., Bridgewater, New Jersey 08807 ("Aventis"). INTRODUCTION WHEREAS, Regeneron and Aventis are Parties to a Collaboration Agreement, having an Effective Date of September